Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +49.99%
#3 Galxe Galxe +35.17%
#4 Derive Derive +31.29%
#5 Infinity Ground Infinity Ground +29.18%
#6 Wiki Cat Wiki Cat +25.33%
#7 Audiera Audiera +24.94%
#8 Fuzzybear Fuzzybear +22.68%
#9 Fetch.ai Fetch.ai +22.26%
#10 Wrapped QUIL Wrapped QUIL +21.56%
Coin of the day
Velas Velas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Classifica tra le azioni #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Prezzo delle azioni
$0.00001
Capitalizzazione di mercato
$50.01K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia MultiCell Technologies, Inc. (MCET)

Categoria

Healthcare
Capitalizzazione di mercato
Ricavi
altro
Utili
Storico dei prezzi
Rapporto P/E
Rapporto P/S
Rapporto P/B
Margine operativo
EPS
Frazionamenti azionari
Dividendi
Rendimento da dividendi
Azioni in circolazione
EPS per MultiCell Technologies, Inc. (MCET)
EPS al August 2015 TTM: $0.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di MultiCell Technologies, Inc., l’EPS attuale della società (TTM) è $0.00. Alla fine del 2013, la società aveva un EPS di $0.00 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per MultiCell Technologies, Inc. da 2013 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) 0.00 -83.33%
2014 0.00 -83.33%
2013 0.00 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $3.62 134,059.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 572,862.96%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 1,596,937.04%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 356,225.93%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 110,270.37%
AU